Manuscript Writing Panel

Investigator Affiliations
Marcin W. Wlodarski, MD, PhD
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Adrianna Vlachos, MD 

Cohen Children’s Medical Center, Hematology/Oncology and Cellular Therapy, New Hyde Park, New York, USA. 

Feinstein Institutes for Medical Research, Manhasset, New York, USA. 

Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Jason E. Farrar, MD  Arkansas Children’s Research Institute and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 
Lydie M. Da Costa, MD, PhD 

Hôpital R. DEBRE, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, F-75019, Paris, France 

HEMATIM, EA4666, UPJV, F-80000, Amiens, France

Laboratoire d'excellence des globules rouges - GR-Ex, France. 

Antonis Kattamis, MD  First Department of Pediatrics, National and Kapodistrian University of Athens, Greece. 
Irma Dianzani, MD, PhD  Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy. 
Cristina Belendez, MD 

Pediatric Hematology and Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain. 

Facultad de Medicina, Universidad Complutense de Madrid, Spain. 

Instituto Investigación Sanitaria Gregorio Marañón, Madrid, Spain. 

Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. 

Sule Unal, MD  Hacettepe University, Department of Pediatric Hematology and Research Center for Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Ankara, Turkey 
Hannah Tamary, MD 

The Rina Zaizov Hematology-Oncology Division, Schneider Children's Medical Center of Israel 

Felsenstain Medical Research Center, Sackler School of Medicine, Tel-Aviv University, Israel 

Ramune Pasauliene, MD  Vilnius University Hospital Santaros Klinikos, Lithuania 
Dagmar Pospisilova, MD, PhD  Department of Pediatrics, Faculty Hospital of Palacky University, Czech Republic. 
Josu de la Fuente, PhD, FRCP 

Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK. 

Department of Immunology & Inflammation, Imperial College London, London, UK. 

Deena Iskander, MD, PhD, FRCPath 

Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK 

Department of Immunology & Inflammation, Imperial College London, London, UK 

Lawrence Wolfe, MD 

Cohen Children’s Medical Center, Hematology/Oncology and Cellular Therapy, New Hyde Park, New York, USA. 

Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA. 

Johnson M. Liu, MD  Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA 
Akiko Shimamura, MD, PhD  Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, USA. 
Katarzyna Albrecht, MD, PhD  Department of Oncology, Paediatric Haematology, Clinical Transplantology and Paediatrics, Medical University of Warsaw, Warsaw, Poland 
Birgitte Lausen, MD, PhD  Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark 
Anne Grete Bechensteen, MD, PhD  Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway 
Ulf Tedgard, MD, PhD  Department of Pediatric Hematology and Oncology, Skåne University Hospital, Lund, Sweden 
Alexander Puzik, MD  Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany 
Paola Quarello, MD  Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy. 
Ugo Ramenghi, MD  Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy. 
Marije Bartels, MD, PhD  Pediatric Hematology Department, University Medical Center Utrecht, Utrecht, The Netherlands 
 Heinz Hengartner, MD  Pediatric Hospital of Eastern Switzerland St. Gallen, Switzerland 
Roula A. Farah, MD  Department of Pediatrics, LAU Medical Center, Rizk Hospital- Beirut, Lebanon 
Mahasen Al Saleh, MD  King Faisal Hospital and Research Center Riyadh, Saudi Arabia. 
Amir Ali Hamidieh, MD  Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Iran. 
Wan Yang, MD  State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, China. 
Etsuro Ito, MD, PhD  Department of Pediatrics, Hirosaki University Graduate School of Medicine, Japan 
Hoon Kook, MD, PhD  Chonnam National University Hwasun Hospital, Gwangju, South Korea. 
Galina Ovsyannikova, MD, PhD  Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia. 
Leo Kager, MD, PhD  St. Anna Children's Hospital, Department of Pediatrics, Medical University Vienna; Children's Cancer Research Institute, Vienna, Austria. 
Pierre-Emmanuel Gleizes, PhD  Pediatric Immunology and Hematology Department, and CRMR aplasies médullaires. Robert Debré Hospital, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, Paris, France 
Jean-Hugues Dalle, MD, PhD  German Cancer Consortium (DKTK), Freiburg, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany. 
Brigitte Strahm, MD  Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 
Charlotte M. Niemeyer, MD

Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

 

German Cancer Consortium (DKTK), Freiburg, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jeffrey M. Lipton, MD, PhD

Cohen Children’s Medical Center, Hematology/Oncology and Cellular Therapy, New Hyde Park, New York, USA.

Feinstein Institutes for Medical Research, Manhasset, New York, USA.

Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Thierry M. Leblanc, MD Pediatric Immunology and Hematology Department, and CRMR aplasies médullaires. Robert Debré Hospital, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, Paris, France

Additional Members

We would also like to acknowledge additional members of the international DBA syndrome guideline panel: 

Content group experts:

Blanche Alter, Eva Atsidaftos, Neelam Giri, Bertil Glader, and Colin Sieff (USA), Luiz Guilherme Darrigo Junior (Brazil), Johan Flygare and Stefan Karlsson (Sweden), Marika Grönroos (Finland), Ina Hainmann (Germany), Lukasz Hutnik (Poland), Alyson McInnes (The Netherlands), Lihong Shi (China), and Nataliya Smetanina (Russia). 

Clinicians and scientists facilitating the discussion:

Amina Szvetnik, Regine Grosse, and Doris Steinemann (Germany), Polyxeni Delaporta (Greece), Vijay G Sankaran and Steven Ellis (USA), Elsbeth M Payne and Alan J Warren (UK), Susana Navarro and Juan A Bueren (Spain), Marieke Von Lindern and Marc Bierings (The Netherlands), Isabelle Marie and Marie-Françoise O’Donohue (France), Denis LJ Lafontaine (Belgium), Jan Valka (Czech Republic), Maryam Behfar (Iran), Anupama Narla (USA), Anna Aspesi (Italy), Anna Beatriz Willemes Batalha and Simone de Castro Resende Franco (Brazil), Lukasz Dembinski (Poland), Amee J George and Ross D Hannan (Australia).